UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
Specialized Disclosure Report
Ultralife Corporation
(Exact name of Registrant as specified in its charter)
Delaware
(Jurisdiction of incorporation or organization)
000-20852
(Commission file number)
2000 Technology Parkway, Newark, New York 14513
(Address of principal executive offices)
Philip A. Fain 315-332-7100
(Name and telephone number of the person to contact in connection with this report)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this report applies:
x | Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2015 |
Section 1 Conflict Minerals Disclosure
Items 1.01 and 1.02 Conflict Minerals Disclosure and Report, Exhibit
A copy of Ultralife Corporations Conflict Minerals Report for the year ended December 31, 2015, is provided as Exhibit 1.01 hereto and is publicly available at http://www.investor.ultralifecorporation.com
Section 2 Exhibits
Exhibit 1.01 Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
ULTRALIFE CORPORATION
(registrant)
By: | /s/ Philip A. Fain | |
Philip A. Fain | ||
Title: | Chief Financial Officer and Treasurer | |
Date: | May 26, 2016 |